Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Predicted Market Size Of The Plasma Fractionation Industry By 2029?

Over the past few years, the plasma fractionation market has seen substantial growth. The market value is expected to rise from $31.42 billion in 2024 to $34.14 billion in 2025, with a compound annual growth rate (CAGR) of 8.6%. Factors contributing to this growth during the historic period include an increasing occurrence of hemophilia and immunodeficiency disorders, an aging population, a surge in demand for immunoglobulins, and the development of more plasma collection centers. Additionally, the number of surgical procedures have also been on the rise.

In the coming years, a swift expansion is anticipated for the plasma fractionation market, reaching a projected value of $50.54 billion in 2029, with a 10.3% compound annual growth rate (CAGR). This growth in the forecast range is predicated on a surge in global health care spending, heightened use of plasma-based medicinal products, an increase in R&D investment, the need for plasma in handling neurological conditions, and the enlargement of plasma fractionation facilities. Key trends for the forecast period include the emergence of novel fractionation technologies, a move towards albumin and immunoglobulin treatments, growing demand for specific plasma products, emphasis on pathogen inactivation methodologies, as well as strategic alliances and collaborations within the plasma sector.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7543&type=smp

Which Growth Drivers Are Shaping The Plasma Fractionation Market Outlook?

The plasma fractionation market is predicted to experience expansive growth due to the rising prevalence of chronic illnesses. Chronic illnesses are typically defined as conditions that persist for at least one year and necessitate continuous medical intervention. Some prevalent examples of these diseases include heart disease, cancer, and diabetes. The administration of plasma products to patients suffering from these chronic conditions not only diminishes morbidity but also enhances their quality of life in a cost-effective manner. This leads to an increased demand for plasma fractionation. To illustrate, a report released by the US-based National Library of Medicine in January 2023 projected that the number of individuals aged 50 and above living with one or more chronic diseases would rise by 99.5% to reach 142.66 million by 2050, a significant increase from 71.522 million in 2020 in the United States. As such, the escalating incidence of chronic diseases is spurring on the growth of the healthcare analytical testing service market. Hence, the anticipated surge in chronic diseases across all age groups is expected to encourage the growth of the plasma fractionation market.

How Is The Global Plasma Fractionation Market Broken Down By Segment?

The plasma fractionation market covered in this report is segmented –

1) By Product: Immunoglobulins, Coagulation Factors, Albumin, Protease Inhibitors

2) By Application: Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology

3) By End User: Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes

Subsegments:

1) By Immunoglobulins: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)

2) By Coagulation Factors: Factor VIII, Factor IX, Prothrombin Complex Concentrates (PCC)

3) By Albumin: Human Albumin, Bovine Serum Albumin (BSA)

4) By Protease Inhibitors: Alpha-1 Antitrypsin (AAT), C1 Esterase Inhibitor (C1-INH)

Which Trends Are Likely To Redefine Growth Paths In The Plasma Fractionation Market?

Main players in the market are coming up with innovative technologies, including state-of-the-art facility treatments that transform donated human plasma into vital medications. They also utilize cutting-edge technology for more secure and efficient processing. For instance, CSL Behring, based in Germany, inaugurated a $470 million plasma fractionation facility in March 2023, which harnesses ground-breaking technology to enhance plasma processing’s safety and efficiency, thereby ensuring the production of higher quality and more reliable medications. The facility contributes to the increased availability of these crucial drugs, thereby satisfying the escalating demand and assuring that more individuals can avail of the life-saving remedies. Thanks to sophisticated automation and self-sanitizing systems, the risk of contamination is decreased and hygienic conditions are improved, thereby augmenting patient safety.

Who Are The Primary Market Leaders In The Plasma Fractionation Market?

Major companies operating in the plasma fractionation market include Baxter International Inc., Bio Products Laboratory Limited, Biotest AG, CSL Limited, Grifols S. A, ADMA Biologics Inc., Green Cross Corporation, Hualan Bioengineering Inc., Intas Pharmaceuticals Ltd., Japan Blood Products Organization, Kedrion S. P. A., Kamada Ltd., LFB Biomedicaments S. A. S, Octapharma AG, Sanquin Plasma Products B. V., Shanghai Raas Blood Products Co. Ltd., Takeda Pharmaceutical Company, Terumo BCT, China Biologic Products Holdings Inc., China National Biotec Group, Emergent BioSolutions Inc., Bharat Serum Vaccines Limited, Plasma Therapeutics, Prothya Biosolutions B. V., BioPharma Plasma LLC, BioLife Plasma Services LP

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

Which Regional Markets Are Emerging As Key Hubs For The Plasma Fractionation Market?

North America was the largest region in the plasma fractionation market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=7543&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model